Stock AVTE AEROVATE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aerovate Therapeutics, Inc.

Equities

AVTE

US0080641071

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
18.9 USD +15.67% Intraday chart for Aerovate Therapeutics, Inc. +11.18% -16.48%
May. 13 Aerovate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 12 Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AEROVATE THERAPEUTICS, INC. Stock Aerovate Therapeutics, Inc.
 544M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 59.34B -
LONZA GROUP AG Stock Lonza Group AG
 40.24B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.88B
CELLTRION, INC. Stock Celltrion, Inc.
 28.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 27.26B
  1. Stock Market
  2. Equities
  3. AVTE Stock
  4. Charts Aerovate Therapeutics, Inc.
  5. Sector Chart